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Suicide	risk	and	prevention	during	the	COVID19	pandemic.			
	
	
	
	
The	mental	health	effects	of	the	COVID-19	pandemic	might	be	profound[1]	and	there	are	
suggestions	that	suicide	rates	will	rise,	though	this	is	not	inevitable.	Suicide	is	likely	to	become	a	
more	pressing	concern	as	the	pandemic	spreads	and	has	longer-term	effects	on	the	general	
population,	the	economy	and	vulnerable	groups.	Preventing	suicide	therefore	needs	urgent	
consideration.	The	response	must	capitalise	on,	but	extend	beyond,	general	mental	health	policies	
and	practices.		
	
There	is	some	evidence	that	suicides	increased	in	the	USA	during	the	1918-19	influenza	
pandemic[2]and	among	older	people	in	Hong	Kong	during	the	2003	SARS	epidemic[3].The	current	
context	is	different	and	evolving.	A	wide-ranging	interdisciplinary	response	that	recognises	how	the	
pandemic	might	heighten	risk	and	applies	knowledge	about	effective	suicide	prevention	approaches	
is	key.	Selective,	indicated	and	universal	interventions	are	required	(see	Panel).		
	
The	likely	adverse	effects	of	the	pandemic	on	people	with	mental	illness,	and	on	population	mental	
health	in	general,	might	be	exacerbated	by	fear,	self-isolation	and	physical	distancing[4].	Suicide	risk	
might	be	increased	because	of	COVID19-related	stigma	towards	affected	individuals	and	their	
families.	Those	with	psychiatric	disorders	might	experience	worsening	symptoms	and	others	might	
develop	new	mental	health	problems,	especially	depression,	anxiety	and	post-traumatic	stress	(all	
associated	with	increased	suicide	risk).	These	will	be	experienced	by	the	general	population	and	
those	with	high	levels	of	exposure,	like	frontline	health	care	workers.	The	consequences	for	mental	
health	services	are	already	being	felt	(e.g.,	increased	workloads	and	the	need	to	find	new	ways	of	
working).	Some	services	are	developing	expertise	in	conducting	psychiatric	assessments	and	
delivering	interventions	remotely	(e.g.,	by	telephone,	digitally);	this	should	be	implemented	more	
widely,	but	with	consideration	that	not	all	patients	will	feel	comfortable	with	such	interactions	and	
they	may	present	implications	for	privacy.	Making	evidence-based	online	resources	and	
interventions	freely	available	at	scale	could	benefit	population	mental	health.	
	
People	in	suicidal	crises	require	special	attention.	Some	might	not	seek	help,	fearing	that	services	are	
overwhelmed	and	that	attending	face-to-face	appointments	might	put	them	at	risk.	Others	might	
seek	help	from	voluntary	sector	crisis	helplines	which	might	be	stretched	beyond	capacity	due	to	
surges	in	calls	and	reductions	in	volunteers.	Mental	health	services	should	develop	clear	remote	
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assessment	and	care	pathways	for	suicidal	individuals	and	staff	training	to	support	new	ways	of	
working	(see	Royal	College	of	Psychiatrists	guidance:	https://www.rcpsych.ac.uk/about-
us/responding-to-covid-19/responding-to-covid-19-guidance-for-clinicians).	Helplines	will	require	
support	to	maintain/increase	their	volunteer	workforce	and	offer	them	more	flexible	methods	of	
working.	Digital	training	resources	would	enable	those	who	have	not	previously	worked	with	suicidal	
individuals	to	take	active	roles	in	mental	health	services	and	helplines.	Evidence-based	online	
interventions	and	apps	should	be	made	available	to	support	suicidal	individuals[5].		
	
Loss	of	employment	and	financial	stressors	are	well-recognised	risk	factors	for	suicide[6].	
Governments	should	provide	financial	safety	nets	(e.g.,	food/housing/unemployment	supports).	
Consideration	must	be	given	not	only	to	individuals’	current	situations	but	also	their	futures.	For	
example,	many	young	people	have	had	their	education	interrupted	and	are	anxious	about	their	
prospects.	Educational	institutions	must	seek	alternative	ways	to	deliver	curricula	and	governments	
need	to	be	prepared	to	offer	them	financial	support	if	necessary.	Active	labour	market	programmes	
will	also	be	crucial	[6].	
	
The	pandemic	might	adversely	affect	other	known	precipitants	of	suicide.	For	example,	domestic	
violence	and	alcohol	consumption	might	increase	during	lockdown.	Public	health	responses	must	
ensure	that	those	facing	interpersonal	violence	are	supported	and	that	safe	drinking	messages	are	
communicated.	Social	isolation,	entrapment	and	loneliness	contribute	to	suicide	risk	[7]	and	are	
likely	to	increase	during	the	pandemic,	particularly	for	bereaved	individuals.	Providing	community	
support	for	those	living	alone	and	encouraging	families/friends	to	‘check	in’	is	helpful.	Easily	
accessible	help	for	bereaved	individuals	is	critical.		
	
Access	to	means	is	a	major	risk	factor	for	suicide.	In	the	current	environment,	certain	lethal	means	
(e.g.	firearms/pesticides/analgesics)	might	be	more	readily	available,	‘stockpiled’	in	homes.	Retailers	
selling	such	products	should	be	especially	vigilant	when	dealing	with	distressed	individuals.	
Governments	and	NGOS	should	consider	temporary	sales	restrictions	(e.g.	on	quantities)	and	deliver	
carefully	framed	messages	about	reducing	access	to	commonly	used	and	highly	lethal	suicide	means.	
	
Irresponsible	media	reporting	of	suicide	can	lead	to	spikes	in	suicides	[8].	Repeated	exposure	to	
stories	about	the	crisis	can	increase	fear[9]	and	heighten	suicide	risk.	Media	professionals	should	
ensure	that	reporting	follows	existing	[10]	and	COVID-19-specific	guidelines	
3	
	
UOB	Open	
(https://www.iasp.info/pdf/2020_briefing_statement_ABversion_reporting_on_suicide_during_covi
d19.pdf).		
	
Comprehensive	responses	should	be	informed	by	enhanced	surveillance	of	COVID-19-related	risk	
factors	contributing	to	suicidal	behaviours.	Some	suicide	and	self-harm	registers	are	now	collecting	
data	on	COVID-19-related	stressors	contributing	to	the	episode,	summaries	of	these	data	will	
facilitate	timely	public	health	responses.	Repeat	representative	cross-sectional	and	longitudinal	
surveys	will	help	identify	increases	in	population-level	risk,	as	might	anonymised	real-time	data	on	
caller	concerns	from	helplines.	Monitoring	demands	and	capacity	of	mental	healthcare	providers	
over	coming	months	is	also	essential	to	ensure	resources	are	directed	to	those	parts	of	the	system	
under	greatest	pressure.	These	efforts	need	to	be	appropriately	resourced	and	coordinated.		
	
The	suicide-related	consequences	of	the	pandemic	might	vary	depending	on	countries’	public	health	
control	measures,	sociocultural/demographic	structures,	availability	of	digital	alternatives	to	face-to-	
face	consultation	and	existing	supports.	The	effects	might	be	worse	in	resource	poor	settings	where	
economic	adversity	will	be	compounded	by	inadequate	welfare	supports.	Other	concerns	in	these	
settings	include	social	effects	of	banning	religious	gatherings	and	funerals,	interpersonal	violence,	
unintended	consequences	of	alcohol	bans,	and	vulnerable	migrant	workers.	COVID-19	related	stigma	
and	misinformation	may	be	particularly	acute	in	these	settings.	Many	of	the	solutions	proposed	
above	will	be	applicable	globally,	but	additional	efforts	will	be	required	in	resource	poor	settings.	
	
These	are	unprecedented	times.	The	pandemic	will	cause	distress	and	leave	many	vulnerable.	
Mental	health	consequences	are	likely	to	be	present	for	longer	and	peak	later	than	the	actual	
pandemic.	However,	research	evidence	and	the	experience	of	national	strategies	provide	a	strong	
basis	for	suicide	prevention.	We	should	be	prepared	to	take	the	actions	highlighted	here,	backed	by	
vigilance	and	international	collaboration.	
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